Top compounds associated with response to NUGGC


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.18 2e-06
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 2e-06
mRNA ruxolitinib CTRPv2 pan-cancer AAC -0.17 2e-06
mRNA Rapamycin gCSI pan-cancer AAC 0.31 3e-06
mRNA PD-0325901 gCSI pan-cancer AAC -0.29 4e-06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 5e-06
mRNA YM-155 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA nelarabine CTRPv2 pan-cancer AAC -0.16 4e-05
Download CSV